TipRanks
Pure Bioscience (PURE)
OTHER OTC:PURE
US Market
PURE
Pure Bioscience
RESEARCH TOOLSreports
Want to see PURE full AI Analyst Report?

Pure Bioscience (PURE) Ratios

46 Followers

Pure Bioscience Ratios

PURE's free cash flow for Q3 2026 was $0.53. For the 2026 fiscal year, PURE's free cash flow was decreased by $ and operating cash flow was $-1.02. See a summary of the company’s cash flow.
Ratios
TTM
Jul 25Jul 24Jul 23Jul 22
Liquidity Ratios
Current Ratio
 0.42 1.12 1.10 3.02 6.72
Quick Ratio
 0.36 0.97 1.02 2.85 6.41
Cash Ratio
 0.27 356.08 0.48 2.06 5.90
Solvency Ratio
 -0.03 -0.39 -0.87 -2.48 -5.71
Operating Cash Flow Ratio
 -0.49 -2.15 -3.45 -6.16 -4.21
Short-Term Operating Cash Flow Coverage
 -0.65 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -5.85M$ -5.13M$ -2.88M$ 51.00K$ 3.29M
Leverage Ratios
Debt-to-Assets Ratio
 4.17 0.49 3.61 0.56 0.00
Debt-to-Equity Ratio
 -1.11 -0.10 -1.03 3.75 0.00
Debt-to-Capital Ratio
 9.87 -0.11 34.69 0.79 0.00
Long-Term Debt-to-Capital Ratio
 -1.79 -0.11 34.69 0.79 0.00
Financial Leverage Ratio
 -0.27 -0.21 -0.29 6.71 1.15
Debt Service Coverage Ratio
 <0.01 -7.02 -19.66 -273.57 -545.33
Interest Coverage Ratio
 >-0.01 -7.60 -20.20 -281.64 -570.83
Debt to Market Cap
 0.79 0.05 0.33 0.11 0.00
Interest Debt Per Share
 2.76 <0.01 0.03 <0.01 <0.01
Net Debt to EBITDA
 29.81 158.95 -0.85 0.02 1.04
Profitability Margins
Gross Profit Margin
53803.55%59.17%58.69%51.73%53.97%
EBIT Margin
-74.90%-95.37%-162.76%-210.28%-188.07%
EBITDA Margin
7.64%-95.28%-155.22%-204.05%-176.58%
Operating Profit Margin
-79.11%-103.18%-159.50%-210.07%-184.84%
Pretax Profit Margin
-91.04%-108.95%-170.66%-211.03%-188.40%
Net Profit Margin
-91.04%-108.95%-170.66%-211.03%-188.72%
Continuous Operations Profit Margin
-91.04%-108.95%-170.66%-211.03%-188.40%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.17%
EBT Per EBIT
115.08%105.59%106.99%100.46%101.93%
Return on Assets (ROA)
-141.53%-226.75%-409.54%-217.04%-77.99%
Return on Equity (ROE)
38.73%46.89%116.97%-1456.25%-89.46%
Return on Capital Employed (ROCE)
91.41%-1893.33%-3683.53%-304.95%-87.62%
Return on Invested Capital (ROIC)
-291.19%-20.45%-3683.53%-304.95%-87.62%
Return on Tangible Assets
-141.53%-226.75%-409.54%-217.04%-77.99%
Earnings Yield
-31.28%-23.88%-37.53%-41.83%-19.98%
Efficiency Ratios
Receivables Turnover
 10.01 4.65 6.59 6.59 9.22
Payables Turnover
 1.25K 1.15 1.35 2.15 1.75
Inventory Turnover
 3.88K 6.38 14.48 10.30 4.77
Fixed Asset Turnover
 269.11 0.20 151.00 8.49 2.99
Asset Turnover
 1.55 2.08 2.40 1.03 0.41
Working Capital Turnover Ratio
 -1.11 24.33 3.43 0.86 0.67
Cash Conversion Cycle
 36.27 -182.49 -189.87 -79.14 -92.63
Days of Sales Outstanding
 36.47 78.57 55.41 55.42 39.59
Days of Inventory Outstanding
 0.09 57.25 25.20 35.45 76.59
Days of Payables Outstanding
 0.29 318.31 270.49 170.01 208.82
Operating Cycle
 36.56 135.82 80.61 90.87 116.19
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.02 -0.02 -0.03 -0.03
Free Cash Flow Per Share
 -0.02 -0.02 -0.02 -0.03 -0.03
CapEx Per Share
 0.00 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.03
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -99.33 -29.85
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -99.33 -29.85
Operating Cash Flow Coverage Ratio
 -0.27 -3.85 -0.86 -3.21 0.00
Operating Cash Flow to Sales Ratio
 -0.73 -0.92 -1.29 -1.75 -1.30
Free Cash Flow Yield
-21.53%-20.06%-28.35%-34.97%-14.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.23 -4.20 -2.66 -2.39 -5.00
Price-to-Sales (P/S) Ratio
 3.41 4.56 4.55 5.04 9.44
Price-to-Book (P/B) Ratio
 -1.21 -1.96 -3.12 34.81 4.48
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.65 -4.99 -3.53 -2.86 -7.00
Price-to-Operating Cash Flow Ratio
 -3.96 -4.99 -3.53 -2.89 -7.24
Price-to-Earnings Growth (PEG) Ratio
 -0.13 0.15 0.17 0.25 -0.10
Price-to-Fair Value
 -1.21 -1.96 -3.12 34.81 4.48
Enterprise Value Multiple
 74.50 154.16 -3.78 -2.45 -4.31
Enterprise Value
 13.78M -323.43M 11.53M 9.40M 14.11M
EV to EBITDA
 74.50 154.16 -3.78 -2.45 -4.31
EV to Sales
 5.69 -146.88 5.87 5.01 7.61
EV to Free Cash Flow
 -7.74 160.51 -4.55 -2.84 -5.65
EV to Operating Cash Flow
 -7.74 160.51 -4.55 -2.87 -5.84
Tangible Book Value Per Share
 -0.05 -0.05 -0.03 <0.01 0.04
Shareholders’ Equity Per Share
 -0.05 -0.05 -0.03 <0.01 0.04
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.02 0.02 0.02 0.02 0.02
Net Income Per Share
 -0.02 -0.02 -0.03 -0.04 -0.04
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.22 1.14 1.05 1.00 1.00
Research & Development to Revenue
 130.47 0.14 0.15 0.16 0.17
SG&A to Revenue
 1.35K 1.48 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.12 0.07 0.11 0.17 0.31
Income Quality
 0.81 0.84 0.76 0.83 0.69
Currency in USD